KPJ Healthcare Berhad Crecimiento futuro

Future controles de criterios 2/6

Se prevé un crecimiento anual de los beneficios y los ingresos de KPJ Healthcare Berhad de 10.8% y 6.3% por año respectivamente. Se prevé que el BPA crezca en un 9.2% al año. Se espera que la rentabilidad financiera sea de 13.4% en 3 años.

Información clave

10.8%

Tasa de crecimiento de los beneficios

9.2%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	2.4%
Tasa de crecimiento de los ingresos	6.3%
Rentabilidad financiera futura	13.4%
Cobertura de analistas	Good
Última actualización	26 Nov 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

KPJ Healthcare Berhad (KLSE:KPJ) Shares Could Be 37% Below Their Intrinsic Value Estimate

Nov 07

Is There An Opportunity With KPJ Healthcare Berhad's (KLSE:KPJ) 33% Undervaluation?

Jun 24

KPJ Healthcare Berhad's (KLSE:KPJ) Dividend Will Be MYR0.01

Jun 02

Here's Why KPJ Healthcare Berhad (KLSE:KPJ) Has Caught The Eye Of Investors

Mar 25

KPJ Healthcare Berhad (KLSE:KPJ) Shares Could Be 37% Below Their Intrinsic Value Estimate

Mar 11

KPJ Healthcare Berhad's (KLSE:KPJ) Shares May Have Run Too Fast Too Soon

Feb 14

Is KPJ Healthcare Berhad (KLSE:KPJ) Using Too Much Debt?

Jan 23

Returns At KPJ Healthcare Berhad (KLSE:KPJ) Appear To Be Weighed Down

Jan 09

KPJ Healthcare Berhad's (KLSE:KPJ) Intrinsic Value Is Potentially 31% Above Its Share Price

Jun 06

These 4 Measures Indicate That KPJ Healthcare Berhad (KLSE:KPJ) Is Using Debt Reasonably Well

May 03

KPJ Healthcare Berhad (KLSE:KPJ) Has More To Do To Multiply In Value Going Forward

Mar 07

KPJ Healthcare Berhad's (KLSE:KPJ) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 20

KPJ Healthcare Berhad's (KLSE:KPJ) Intrinsic Value Is Potentially 26% Above Its Share Price

Jan 31

KPJ Healthcare Berhad (KLSE:KPJ) Is Increasing Its Dividend To MYR0.0055

Sep 15

KPJ Healthcare Berhad's (KLSE:KPJ) Shareholders Will Receive A Bigger Dividend Than Last Year

Sep 01

Capital Allocation Trends At KPJ Healthcare Berhad (KLSE:KPJ) Aren't Ideal

Aug 11

Previsiones de crecimiento de beneficios e ingresos

KLSE:KPJ - Estimaciones futuras de los analistas y datos financieros pasados (MYR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	4,346	381	608	763	15
12/31/2025	4,069	347	489	718	15
12/31/2024	3,775	311	547	732	15
9/30/2024	3,764	300	358	684	N/A
6/30/2024	3,657	304	370	639	N/A
3/31/2024	3,512	303	350	591	N/A
12/31/2023	3,419	281	417	658	N/A
9/30/2023	3,254	275	364	583	N/A
6/30/2023	3,128	235	324	548	N/A
3/31/2023	3,042	211	282	527	N/A
12/31/2022	2,868	179	226	460	N/A
9/30/2022	2,792	122	284	555	N/A
6/30/2022	2,692	84	250	485	N/A
3/31/2022	2,626	64	225	470	N/A
12/31/2021	2,590	55	195	412	N/A
9/30/2021	2,560	58	122	368	N/A
6/30/2021	2,495	79	128	386	N/A
3/31/2021	2,338	85	93	307	N/A
12/31/2020	2,397	110	95	337	N/A
9/30/2020	1,853	169	160	415	N/A
6/30/2020	2,138	182	110	446	N/A
3/31/2020	2,523	211	132	535	N/A
12/31/2019	2,738	211	177	581	N/A
9/30/2019	3,581	180	148	604	N/A
6/30/2019	3,483	176	167	560	N/A
3/31/2019	3,424	176	174	543	N/A
12/31/2018	3,366	179	131	518	N/A
9/30/2018	3,279	188	3	381	N/A
6/30/2018	3,246	177	N/A	296	N/A
3/31/2018	3,224	168	N/A	359	N/A
12/31/2017	3,180	166	N/A	362	N/A
9/30/2017	3,040	161	N/A	279	N/A
6/30/2017	3,018	162	N/A	391	N/A
3/31/2017	3,005	160	N/A	239	N/A
12/31/2016	2,970	154	N/A	143	N/A
9/30/2016	2,978	124	N/A	187	N/A
6/30/2016	2,933	130	N/A	115	N/A
3/31/2016	2,882	136	N/A	192	N/A
12/31/2015	2,848	135	N/A	189	N/A
9/30/2015	2,862	158	N/A	338	N/A
6/30/2015	2,798	149	N/A	322	N/A
3/31/2015	2,746	147	N/A	339	N/A
12/31/2014	2,639	143	N/A	319	N/A
9/30/2014	2,556	126	N/A	270	N/A
6/30/2014	2,464	117	N/A	174	N/A
3/31/2014	2,389	108	N/A	140	N/A
12/31/2013	2,332	103	N/A	144	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (10.8% al año) de KPJ es superior a la tasa de ahorro (3.6%).

Beneficios vs. Mercado: Se prevé que los beneficios (10.8% al año) de KPJ crezcan menos que el mercado MY (11% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de KPJ crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (6.3% al año) de KPJ crezcan más rápidamente que los del mercado MY (6.2% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 6.3% al año) de KPJ crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de KPJ sea baja dentro de 3 años (13.4%).

KPJ Healthcare Berhad Crecimiento futuro

Future controles de criterios 2/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 7.4% to RM1.93

Price target increased by 8.3% to RM1.72

Price target increased by 8.6% to RM1.48

Consensus EPS estimates increase by 25%

Price target increased by 8.7% to RM1.23

Consensus EPS estimates increase by 30%

Recent updates

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

KPJ Healthcare Berhad (KLSE:KPJ) Shares Could Be 37% Below Their Intrinsic Value Estimate

KPJ Healthcare Berhad's (KLSE:KPJ) Price Is Out Of Tune With Earnings

KPJ Healthcare Berhad (KLSE:KPJ) Has Affirmed Its Dividend Of MYR0.01

Second quarter dividend of RM0.01 announced

KPJ Healthcare Berhad to Report Q2, 2024 Results on Aug 28, 2024

Second quarter 2024 earnings: Revenues exceed analyst expectations

Returns Are Gaining Momentum At KPJ Healthcare Berhad (KLSE:KPJ)

Do KPJ Healthcare Berhad's (KLSE:KPJ) Earnings Warrant Your Attention?

Is There An Opportunity With KPJ Healthcare Berhad's (KLSE:KPJ) 33% Undervaluation?

Price target increased by 7.4% to RM1.93

KPJ Healthcare Berhad Appoints Encik Mohd Khairul Izzad Bin Mohammed Shamsudin as Chief Financial Officer, Effective June 10, 2024

KPJ Healthcare Berhad's (KLSE:KPJ) Dividend Will Be MYR0.01

First quarter dividend of RM0.01 announced

First quarter 2024 earnings: EPS misses analyst expectations

KPJ Healthcare Berhad, Annual General Meeting, Jun 26, 2024

Here's Why KPJ Healthcare Berhad (KLSE:KPJ) Has Caught The Eye Of Investors

KPJ Healthcare Berhad Announces Resignation of Md Arif Bin Mahmood as Non Independent and Non Executive Chairman, Effective April 1, 2024

KPJ Healthcare Berhad (KLSE:KPJ) Shares Could Be 37% Below Their Intrinsic Value Estimate

Price target increased by 8.3% to RM1.72

Full year 2023 earnings: EPS and revenues exceed analyst expectations

KPJ Healthcare Berhad's (KLSE:KPJ) Shares May Have Run Too Fast Too Soon

Is KPJ Healthcare Berhad (KLSE:KPJ) Using Too Much Debt?

Returns At KPJ Healthcare Berhad (KLSE:KPJ) Appear To Be Weighed Down

Upcoming dividend of RM0.013 per share at 3.0% yield

Price target increased by 8.6% to RM1.48

KPJ Healthcare Berhad to Report Q3, 2023 Results on Nov 28, 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

KPJ Healthcare Berhad Announces Single Tier Special Dividend for the Financial Year Ending 31 December 2023

KPJ Healthcare Berhad Announces Appointment of Keh Ching Tyng as Joint Secretary

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Kpj Healthcare Berhad Announces Appointment of Mr. Chin Keat Chyuan as President, Effective 1 September 2023

KPJ Healthcare Berhad's (KLSE:KPJ) Intrinsic Value Is Potentially 31% Above Its Share Price

KPJ Healthcare Berhad Declares Interim Dividend for the Year Ended December 31, 2023, Payable on July 4, 2023

First quarter 2023 earnings: EPS exceeds analyst expectations

Now 22% undervalued

These 4 Measures Indicate That KPJ Healthcare Berhad (KLSE:KPJ) Is Using Debt Reasonably Well

Full year 2022 earnings released: EPS: RM0.04 (vs RM0.013 in FY 2021)

Now 23% undervalued

Now 22% undervalued

Now 21% undervalued

KPJ Healthcare Berhad (KLSE:KPJ) Has More To Do To Multiply In Value Going Forward

Consensus EPS estimates increase by 25%

Price target increased by 8.7% to RM1.23

KPJ Healthcare Berhad's (KLSE:KPJ) Shareholders Will Receive A Bigger Dividend Than Last Year

Full year 2022 earnings: EPS and revenues exceed analyst expectations

KPJ Healthcare Berhad Announces Single Tier Interim Dividend for the Financial Year End December 31, 2023, Payable on April 14, 2023

Now 21% undervalued

KPJ Healthcare Berhad's (KLSE:KPJ) Intrinsic Value Is Potentially 26% Above Its Share Price

Upcoming dividend of RM0.01 per share

Consensus EPS estimates increase by 30%

Price target increased to RM1.07

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

KPJ Healthcare Berhad Announces Single Tier Interim Dividend for the Financial Year Ended December 31, 2022, Payable on December 28, 2022

KPJ Healthcare Berhad (KLSE:KPJ) Is Increasing Its Dividend To MYR0.0055

KPJ Healthcare Berhad Appoints Encik Hisham Bin Zainal Mokhtar as Independent and Non Executive Member of Risk Committee

KPJ Healthcare Berhad Announces Resignation of Mohd Shukrie Bin Mohd Salleh as Managing Director

KPJ Healthcare Berhad Announces Resignation of Mohd Shukrie Bin Mohd Salleh as Managing Director

KPJ Healthcare Berhad's (KLSE:KPJ) Shareholders Will Receive A Bigger Dividend Than Last Year

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

KPJ Healthcare Berhad Announces Single Tier Interim Dividend for the Fiscal Year Ending December 31, 2022, Payable on 21 October 2022

KPJ Healthcare Berhad Announces the Resignation of TEH PENG PENG as Joint Secretary

KPJ Healthcare Berhad Appoints Nantha Kumar Subramanian as Its New Chief Digital Officer

KPJ Healthcare Berhad Appoints Lee Lai Fan as Independent and Non Executive Director

KPJ Healthcare Berhad Announces Retirement of Puan Lydia Anne Abraham as Independent and Non Executive Director

Consensus EPS estimates fall by 17%

High number of new directors

Now 22% undervalued after recent price drop

KPJ Healthcare Berhad Announces Single Tier Interim Dividend for the Financial Year Ending December 31, 2022, Payable on 29 Jul 2022